Track the Hangzhou Diagens Biotechnology Co., Ltd. - B share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, Hangzhou Diagens Biotechnology Co., Ltd. - B has recorded 1 insider filings. Market capitalisation: €27.5bn. The latest transaction was disclosed on 14 April 2026 (Other). Among the most active insiders: SONG Ning. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hangzhou Diagens Biotechnology Co., Ltd. es una empresa enfocada en el desarrollo de soluciones biofarmacéuticas. Cotiza en la Bolsa de Hong Kong.